EP2664347
Bevacizumab for use in a method for treating atrophic age related macular degeneration
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
13.7.2009EP published:
13.3.2019EP application number:
13179231.9
EPO information:
European Patent Register
Max expiry date:
12.7.2029
Title:
Bevacizumab for use in a method for treating atrophic age related macular degeneration
Timeline
Today
13.7.2009EP application
13.3.2019EP Publication
Owner
Name:
ALLERGAN, INC.Address:
2525 Dupont Drive, 92612, Irvine, CA, US
Inventor
Name:
Robinson, Michael R.Address:
Irvine, CA California, US
Name:
Blanda, Wendy M.Address:
Tustin, CA California, US
Name:
Hughes, Patrick M.Address:
Aliso Viejo, CA California, US
Name:
Burke, A. JamesAddress:
Santa Ana, CA California, US
Name:
Whitcup, Scott M.Address:
Laguna Hill, CA California, US
Priority
Number:
176238Date:
18.7.2008Country:
US
Classification
Categories:
A61K 9/00, A61K 9/16, A61K 31/712, C07K 16/22, A61P 27/02